Authors


Robert M. Pascuzzi, MD

Latest:

AUPN Leadership Minute Episode 8: Engaging Medical Students in Neurology – Part 1

Episode 8 of the AUPN Leadership Minute features Rohit Das, MD, of University of Texas Southwestern Medical Center at Dallas; and Robert M. Pascuzzi, MD, of Indiana University School of Medicine. [WATCH TIME: 4 minutes]


Christen Kutz, PhD, PA-C

Latest:

Managing MS in the Community: Advice and Resources

Advice and resources for colleagues, including community practitioners and neurologists, to encourage collaboration and best support for patients with multiple sclerosis (MS).


John Cerne, BS

Latest:

Stroke Intervention: A New Application of Interventional Neuroradiology

New training pathways are needed to close the gap between capable-physician supply and the growing demand for thrombectomy.


Irfan Qureshi, MD

Latest:

Utilizing the SCACOMS Composite Measure to Assess Treatment Benefit of Troriluzole in Spinocerebellar Ataxia: Irfan Qureshi, MD

The chief medical officer at Biohaven provided insight on its investigational spinocerebellar ataxia agent troriluzole, the advantages of the newly developed SCACOMS measure, and how the therapy stacks against natural history data. [WATCH TIME: 4 minutes]


Craig Zaidman, MD

Latest:

Telehealth Exam for SMA in Children and Adolescents

Crystal Proud, MD, demonstrates a typical neurological telehealth exam for pediatric SMA with one of her patients.


Walter Strapps, PhD

Latest:

Gene Editing as a Promising Treatment Approach for Duchenne Muscular Dystrophy: Walter Strapps, PhD

The chief scientific officer at Liberate Bio discussed how through the advancement of nonviral delivery technologies and nucleic acid therapeutics, genetic medicines can potentially bring relief to patients with Duchenne muscular dystrophy. [WATCH TIME: 5 minutes]


Todd Levine, MD

Latest:

Todd Levine, MD: Synuclein’s Role in Parkinson Disease Diagnosis

The chief medical officer of CND Life Sciences and medical director of Honor Health Neurology spoke to the role synuclein has played in advancing PD diagnosis.


Daniel Kantor, MD

Latest:

Remaining Questions Surrounding COVID-19 Vaccines in MS

Daniel Kantor, MD, discussed the data from his presentation at the 2022 CMSC annual meeting on COVID-19 vaccine response in patients with multiple sclerosis, and what questions are still lingering among the clinical community.


Miia Kivipelto, MD, PhD

Latest:

Creating Innovative Ways to Improve Alzheimer Disease Prevention: Miia Kivipelto, MD, PhD

The professor of clinical geriatric epidemiology at Karolinska Institutet discussed strategies for lowering the risk of Alzheimer disease, and the new ways to approach prevention. [WATCH TIME: 4 minutes]


Bryant Robinson

Latest:

Importance of Telehealth Services for the MS Population

Bryant Robinson, senior manager of government relations at the National MS Society, discussed how telehealth access has become vital for patients with multiple sclerosis who often lack nearby specialist care.


Sarah Anderson, PharmD, NBC-HWC

Latest:

Key Takeaways for MS Providers Regarding Major Medicare Changes Expected in 2025

Sarah Anderson, PharmD, NBC-HWC, senior director of clinical resources and programming at National MS Society, talked about the significant updates under the Inflation Reduction Act to come in 2025 for patients with multiple sclerosis.


Ignacio Mata, PhD

Latest:

Expanding the Genetic Pool of Non-European Populations in Parkinson Disease: Ignacio Mata, PhD

The associate professor of neurology at the Cleveland Clinic Lerner Institute provided insight on a recently published meta-analysis identifying independent genome-wide significant loci whose expression is associated with Parkinson disease risk. [WATCH TIME: 5 minutes]


Michael Kelly, PhD

Latest:

Broad FDA Approval of Gene Therapy Expands Treatment Choices for Duchenne Muscular Dystrophy: Debra Miller & Michael Kelly, PhD

The chief executive officer and the chief scientific officer at CureDuchenne talked about a recent webinar that discussed the broad FDA approval of a gene therapy for Duchenne muscular dystrophy, highlighting patient choice and the ongoing efforts to improve treatments. [WATCH TIME: 9 minutes]


Alicyn Magruder, PharmD, BCACP, MSCS

Latest:

Looking Ahead at MS Treatment and Closing Thoughts on Biosimilars

Jeffrey Cohen, MD; Sarah Anderson, PharmD, NBC-HWC; and Alicyn Magruder, PharmD, BCACP, MSCS, share their final thoughts on the future landscape of clinical MS care in the biosimiliars era. [WATCH TIME: 12 minutes]


Sebastian Palmqvist, MD, PhD

Latest:

Diagnosing Alzheimer Disease With New Blood Tests in Primary Care Settings: Sebastian Palmqvist, MD, PhD

The associate professor of neuroscience at Lund University in Sweden discussed findings from a study of a new blood test examining biomarkers which demonstrated a high accuracy in identifying Alzheimer disease pathology. [WATCH TIME: 5 minutes]


Dongzhe Hong, PhD

Latest:

Reassessing the Process of Drug Development for Duchenne Muscular Dystrophy: Dongzhe Hong, PhD

The postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School discussed some of the issues with ensuring timely care access to approved therapies for patients with Duchenne muscular dystrophy. [WATCH TIME: 3 minutes]


Temitayo Oyegbile-Chidi, MD, PhD

Latest:

Understanding the Role of Sleep in the Emergence of Neurodevelopmental Disorders: Temitayo Oyegbile-Chidi, MD, PhD

The pediatric neurologist at the University of California, Davis, provided perspective on some of the mechanistic links between sleep and neurodevelopmental disorders. [WATCH TIME: 3 minutes]


Michael Okun, MD

Latest:

Michael Okun, MD: Long-Term Plan for Modifying Neurologic Device Approval System

The executive director of the Norman Fixel Institute for Neurological Diseases gave his call-to-action on how to change the approval system for neurologic devices for rare diseases.


Ronald Gavidia, MD, MS

Latest:

Increased Risk of Insomnia in Transgender Youths With Mental Health Disorders: Ronald Gavidia, MD, MS

The clinical assistant professor in the division of Sleep Medicine, Department of Neurology, University of Michigan spoke about the associations of mental health with insomnia in transgender youth. [WATCH TIME: 5 minutes]


Beth Stein, MD

Latest:

Improving Patient Communication in MG

Expert neurologists share thoughts on how to improve patient/physician communication and how listening to the patient needs will aid in managing MG.


Flavia Nelson, MD

Latest:

Practice Pearls for Management of NMOSD

Experts in neurology discuss immune tolerance as an alternative strategy and share practice pearls for approaching treatment of NMOSD.


Laura Kirkpatrick, MD

Latest:

Pediatric AES Insights: Addressing Health Disparities and Advancing Neonatal Epilepsy Care

Pediatric epilepsy specialists Adam Numis, MD, and Laura Kirkpatrick, MD, highlighted efforts to standardize data collection for pediatric epilepsy health equity and improve neonatal epilepsy outcomes.


Mark Lew, MD

Latest:

The Need to Find Valuable Parkinson Disease Biomarkers: Mark Lew, MD

The director of the Division of Movement Disorders at the USC Keck School of Medicine discussed the early reactions behind reflex tears as a potential biomarker for Parkinson disease. [WATCH TIME: 2 minutes]


Margaret Park, MD

Latest:

Future Directions for the Management of Narcolepsy

Margaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide clinical pearls and the future treatment landscape for the management of narcolepsy.v


Mitchell S.V. Elkind, MD, MS, MPhil

Latest:

Improving Access to Stroke Systems of Care: Mitchell S.V. Elkind, MD, MS, MPhil

The president of the American Heart Association discussed the necessary steps to increase access to systems of care in order to improve health overall, including the integration of telemedicine.


Sandi See Tai, MD

Latest:

Promising Innovative Gene Therapy for APOE4 Homozygous Alzheimer Disease: R. Nolan Townsend; Sandi See Tai, MD; Kim G. Johnson, MD

A trio of experts talked about Lexeo Therapeutics’ LX1001 gene therapy trial that demonstrated promising safety and biomarker effects in patients with early-stage Alzheimer disease. [WATCH TIME: 5 minutes]



Gustavo Dziewczapolski, PhD

Latest:

Cure CMD: Benefits of the Biennial SciFam Conference

Rachel Alvarez and Gustavo Dziewczapolski, PhD, of Cure CMD spoke about the benefits of attending the biennial Scientific & Family Conference to learn more about congenital muscle diseases and interact with the patient community.


Dolores Santamaria, MD

Latest:

The Art of Patient Assessment and Knowledge of Treatment Options in Migraine: Dolores D. Santamaria, MD

The director of the Headache Center at Allegheny Health Network talked about the evolution of migraine treatments and highlighted the importance of personalized medicine for patients living with this disabling condition. [WATCH TIME: 10 minutes]


Matthew Allard

Latest:

Sleeping Around the Podcast: Living with Narcolepsy & Cataplexy: The Patient's Perspective

Sleeping Around the Podcast is joined by Rachel Nesmith, a patient with narcolepsy, who shares her story of overcoming the burdens and impairments of living with narcolepsy and cataplexy.

© 2025 MJH Life Sciences

All rights reserved.